[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:trim21-wt-allele":3},{"name":4,"total":5,"recruiting":5,"trials":6},"TRIM21 wt Allele",4,[7,15,22,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07404865","Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease",[11],"Phase 3","RECRUITING","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:29.736989Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06979531","Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity",[19],"Phase 2","2026-08-26T02:18:03.638950Z","2026-05-05T02:43:27.304700Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06440525","A Study of RSLV-132 in Females With Sjögren's Disease",[19],"2026-08-26T02:17:55.355429Z","2026-05-05T02:43:27.061735Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT07607964","A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)",[32],"Phase 1","2026-08-26T02:17:42.501124Z","2026-05-29T15:36:40.226566Z"]